Sildenafil Teva
From £3.99
Understanding the Molecular Science of PDE5 Inhibition
The Biochemical Foundation of Viagra Connect
Viagra Connect's active ingredient, sildenafil citrate, operates through a sophisticated molecular mechanism targeting phosphodiesterase type 5 (PDE5) enzymes. These enzymes naturally break down cyclic guanosine monophosphate (cGMP), a crucial chemical messenger responsible for smooth muscle relaxation in penile blood vessels. By selectively inhibiting PDE5, Viagra Connect allows cGMP levels to remain elevated, promoting sustained vasodilation and improved blood flow to erectile tissues.
The selectivity of sildenafil for PDE5 enzymes represents years of pharmaceutical research. Whilst the human body contains multiple phosphodiesterase enzymes, sildenafil demonstrates approximately 10-fold selectivity for PDE5 over PDE6 and more than 80-fold selectivity over other PDE enzymes. This targeted approach minimises unwanted effects whilst maximising therapeutic benefit for erectile dysfunction.
Pharmacokinetic Profile and Absorption
The pharmacokinetic properties of Viagra Connect follow predictable patterns that inform optimal dosing strategies. After oral administration, sildenafil reaches peak plasma concentrations within 30-120 minutes, with an average time to maximum concentration of approximately 60 minutes when taken on an empty stomach. The bioavailability of sildenafil is around 40%, reflecting first-pass hepatic metabolism through cytochrome P450 enzymes, particularly CYP3A4.
Food intake significantly influences absorption kinetics, particularly high-fat meals which can delay peak concentration by up to 60 minutes whilst reducing maximum plasma levels by approximately 29%. This pharmacokinetic interaction explains clinical recommendations to take Viagra Connect on an empty stomach for optimal effectiveness, though the medication remains functional when taken with food.
The Nitric Oxide Pathway and Sexual Response
Viagra Connect's mechanism intimately connects with the body's natural sexual response pathway. During sexual arousal, nerve stimulation triggers nitric oxide release from endothelial cells lining penile blood vessels. Nitric oxide activates guanylate cyclase, increasing cGMP production and causing smooth muscle relaxation in arterial walls. This cascade permits increased blood flow into erectile chambers whilst simultaneously reducing venous outflow.
Without sexual arousal, this nitric oxide pathway remains inactive, explaining why Viagra Connect doesn't cause automatic erections. The medication amplifies existing physiological responses rather than creating artificial stimulation, maintaining the natural connection between psychological arousal and physical response. This requirement for endogenous nitric oxide production also explains why the medication may be less effective in conditions that impair nerve function or endothelial health.
Duration of Action and Elimination
The therapeutic window of Viagra Connect extends 4-6 hours, determined by sildenafil's elimination half-life of approximately 3-5 hours. During this period, the medication maintains sufficient plasma concentrations to inhibit PDE5 effectively, though peak effectiveness typically occurs within the first 2-3 hours following administration. The medication doesn't accumulate with repeated dosing when taken as recommended (maximum once per 24 hours).
Hepatic metabolism primarily eliminates sildenafil through CYP3A4 and CYP2C9 pathways, producing active metabolites that contribute approximately 20% of the parent compound's pharmacological activity. Renal excretion accounts for roughly 80% of elimination, whilst faecal excretion handles the remainder. This dual elimination pathway explains dosage adjustments recommended for patients with severe hepatic or renal impairment.
Cardiovascular Pharmacology and Safety Considerations
Viagra Connect's cardiovascular effects stem from its mild vasodilatory properties, typically causing modest reductions in blood pressure (average 8-10 mmHg systolic). These effects result from weak inhibition of PDE1 and PDE3 enzymes found in cardiac and vascular smooth muscle. In healthy individuals, compensatory mechanisms maintain cardiovascular stability, but the interaction potential with nitrates creates dangerous hypotensive risks.
The contraindication with nitrate medications reflects serious pharmacological interactions. Nitrates increase cGMP through the same pathway that Viagra Connect preserves, creating synergistic vasodilation that can cause life-threatening hypotension. This interaction remains clinically significant for 24-48 hours after taking sildenafil, reflecting the medication's elimination timeline.
Individual Variation and Clinical Response
Genetic polymorphisms in CYP3A4 enzymes create individual variation in sildenafil metabolism, explaining why some patients require dosage adjustments. Fast metabolisers may experience shorter duration of action, whilst slow metabolisers might experience prolonged effects or increased side effect susceptibility. Age-related changes in hepatic metabolism typically result in 40% higher plasma concentrations in men over 65, though dosage adjustments aren't routinely required unless other factors are present.
EverydayMeds recognises that patients may prefer branded Viagra or choose generic sildenafil containing identical active ingredients. Both options provide the same pharmacological mechanisms and clinical effectiveness, with generic alternatives offering cost savings without compromising therapeutic outcomes. Our clinical assessment process ensures appropriate prescribing regardless of brand preference, with qualified prescribers evaluating individual suitability based on medical history, current medications, and cardiovascular health status.
